Onderneming Essex Bio-Technology Limited Deutsche Boerse AG
Aandelen
EB51
KYG312371035
Farmaceutische producten
Vakgebied
Aantal werknemers: 1 481
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Surgical
55,9
%
| 764 | 58,0 % | 953 | 55,9 % | +24,73% |
Ophthalmology
44,1
%
| 554 | 42,0 % | 753 | 44,1 % | +36,10% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 1 318 | 100,0 % | 1 707 | 100,0 % | +29,51% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hai Zhou Fang
CEO | Chief Executive Officer | 58 | 31-07-00 |
Qi Xue
CTO | Chief Tech/Sci/R&D Officer | 63 | 09-04-18 |
Hian Leng Ngiam
BRD | Director/Board Member | 40 | 01-01-15 |
Lai Man Yau
BRD | Director/Board Member | 60 | 01-01-01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mia Je Ngiam
FOU | Founder | 70 | 01-02-99 |
Lai Man Yau
BRD | Director/Board Member | 60 | 01-01-01 |
Mee Mooi Yeow
BRD | Director/Board Member | 72 | 30-09-04 |
Hai Zhou Fang
CEO | Chief Executive Officer | 58 | 31-07-00 |
Chi Ying Fung
BRD | Director/Board Member | 69 | 13-06-01 |
Hian Leng Ngiam
BRD | Director/Board Member | 40 | 01-01-15 |
Man Sing Yan
BRD | Director/Board Member | 66 | 09-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 567 540 000 | 260 911 033 ( 45,97 %) | 0 | 45,97 % |
Bedrijfsgegevens
Essex Bio-Technology Ltd.
West Tower, Shun Tak Centre 168-200 Connaught Road
, Hong Kong
+
http://www.essexbio.com![Adres Essex Bio-Technology Limited(EB51)](https://cdn.zonebourse.com/static/address/451139.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,08% | 95,18 mld. | |
-4,34% | 37,55 mld. | |
+76,55% | 28,2 mld. | |
-14,61% | 15,63 mld. | |
-3,46% | 13,63 mld. | |
-12,31% | 11,5 mld. | |
+184,77% | 10,81 mld. | |
-54,13% | 9,23 mld. | |
+6,14% | 9,09 mld. |